{"id":"https://openalex.org/W2892009523","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.9001","title":"Nivolumab (Nivo) + platinum-doublet chemotherapy (Chemo) vs chemo as first-line (1L) treatment (Tx) for advanced non-small cell lung cancer (NSCLC) with <1% tumor PD-L1 expression: Results from CheckMate 227.","display_name":"Nivolumab (Nivo) + platinum-doublet chemotherapy (Chemo) vs chemo as first-line (1L) treatment (Tx) for advanced non-small cell lung cancer (NSCLC) with <1% tumor PD-L1 expression: Results from CheckMate 227.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2892009523","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.9001","mag":"2892009523"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.9001","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.9001","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.9001","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012061864","display_name":"Hossein Borghaei","orcid":"https://orcid.org/0000-0002-2577-4454","observed_orcids":["https://orcid.org/0000-0002-2577-4454"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hossein Borghaei","raw_affiliation_strings":["Fox Chase Cancer Center, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Center, Philadelphia, PA;","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029805571","display_name":"Matthew David Hellmann","orcid":"https://orcid.org/0000-0002-2670-9777","observed_orcids":["https://orcid.org/0000-0002-2670-9777"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew David Hellmann","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052765751","display_name":"Luis G Paz-Ares","orcid":"https://orcid.org/0000-0002-1947-3364","observed_orcids":["https://orcid.org/0000-0002-1947-3364"]},"institutions":[{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Luis G. Paz-Ares","raw_affiliation_strings":["Hospital Universitario Doce de Octubre, Madrid, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Doce de Octubre, Madrid, Spain;","institution_ids":["https://openalex.org/I4210101691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088178599","display_name":"Suresh S. Ramalingam","orcid":"https://orcid.org/0000-0002-0757-3106","observed_orcids":["https://orcid.org/0000-0002-0757-3106"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suresh S. Ramalingam","raw_affiliation_strings":["Winship Cancer Institute, Emory University, Atlanta, GA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winship Cancer Institute, Emory University, Atlanta, GA;","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060572768","display_name":"Martin Reck","orcid":"https://orcid.org/0000-0002-5336-9739","observed_orcids":["https://orcid.org/0000-0002-5336-9739"]},"institutions":[{"id":"https://openalex.org/I4210129183","display_name":"German Center for Lung Research","ror":"https://ror.org/03dx11k66","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210129183","https://openalex.org/I4405256427"]},{"id":"https://openalex.org/I4210140903","display_name":"LungenClinic Grosshansdorf","ror":"https://ror.org/041wfjw90","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210140903"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Martin Reck","raw_affiliation_strings":["LungenClinic Grosshansdorf, German Center for Lung Research, Grosshansdorf, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LungenClinic Grosshansdorf, German Center for Lung Research, Grosshansdorf, Germany;","institution_ids":["https://openalex.org/I4210129183","https://openalex.org/I4210140903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033519199","display_name":"Kenneth John O'Byrne","orcid":"https://orcid.org/0000-0002-6754-5633","observed_orcids":["https://orcid.org/0000-0002-6754-5633"]},"institutions":[{"id":"https://openalex.org/I2801814493","display_name":"Princess Alexandra Hospital","ror":"https://ror.org/04mqb0968","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1302211766","https://openalex.org/I2801244131","https://openalex.org/I2801814493","https://openalex.org/I4210089726"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Kenneth John O'Byrne","raw_affiliation_strings":["Princess Alexandra Hospital Brisbane, Queensland, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Alexandra Hospital Brisbane, Queensland, Australia;","institution_ids":["https://openalex.org/I2801814493"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021579217","display_name":"Prabhu Bhagavatheeswaran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Prabhu Bhagavatheeswaran","raw_affiliation_strings":["Bristol-Myers Squibb, Princeton, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Princeton, NJ;","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108482049","display_name":"Faith Ellen Nathan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Faith Ellen Nathan","raw_affiliation_strings":["Bristol-Myers Squibb, Princeton, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Princeton, NJ;","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018401879","display_name":"Julie Renee Brahmer","orcid":"https://orcid.org/0000-0002-2443-8395","observed_orcids":["https://orcid.org/0000-0002-2443-8395"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie R. Brahmer","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD;","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":87,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"9001","last_page":"9001"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.029899999499320984,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9779999852180481},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.9480000138282776},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8479999899864197},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.7059999704360962},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.8500000238418579},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8420000076293945},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6679999828338623},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.746999979019165},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.5910000205039978},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6510000228881836},{"id":"https://openalex.org/keywords/advanced-non-small-cell-lung-cancer","display_name":"advanced non-small cell lung cancer","score":0.44200000166893005}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8567438721656799},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.7584917545318604},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7108853459358215},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6657221913337708},{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.5916762351989746},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.520814061164856},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.425799697637558},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.42127349972724915},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3932657837867737},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.19346296787261963},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.1269281804561615}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.9001","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.9001","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.9001","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2978789901","https://openalex.org/W3029572589","https://openalex.org/W2995826615","https://openalex.org/W3170758021","https://openalex.org/W2890022474","https://openalex.org/W3119218182","https://openalex.org/W7170192048","https://openalex.org/W3113031448","https://openalex.org/W3170341220","https://openalex.org/W2885134066"],"abstract_inverted_index":{"9001":[0],"Background:":[1],"CheckMate":[2,331],"227":[3,332],"(NCT02477826),":[4],"a":[5],"phase":[6],"3":[7,139],"study":[8],"of":[9,29,66,180,274,344,358],"1L":[10,294],"nivo":[11,17,35,95,138,147,183,209,225,246,286,295,338],"+":[12,18,36,96,142,151,184,210,226,247,287,296,339],"ipilimumab":[13],"(ipi),":[14],"nivo,":[15],"or":[16,153],"chemo":[19,21,39,67,97,99,154,159,185,187,211,216,227,229,248,288,297,301,340,342],"vs":[20,38,98,186,228,300,341],"in":[22,40,74,84,100,188,261,302,320],"advanced":[23,305],"NSCLC,":[24,117],"met":[25],"its":[26],"co-primary":[27],"endpoint":[28,179],"prolonged":[30],"progression-free":[31],"survival":[32],"(PFS)":[33],"with":[34,43,86,102,113,190,224,245,285,291,304,327],"ipi":[37,143],"patients":[41],"(pts)":[42],"tumor":[44,88,105,126,132,193,310],"mutational":[45],"burden":[46],"\u226510":[47],"mutations/Mb.":[48],"Identifying":[49],"effective":[50],"tx":[51,70],"for":[52,94,160,176,182,200],"pts":[53,85,101,189,303,326],"without":[54],"known":[55,119],"predictive":[56],"biomarkers":[57],"remains":[58],"an":[59,75],"unmet":[60],"need.":[61],"Prior":[62],"studies":[63],"suggest":[64],"addition":[65],"to":[68,137,168,267,281],"anti\u2013PD-(L)1":[69],"can":[71],"improve":[72],"outcomes":[73],"unselected":[76],"pt":[77],"population,":[78],"although":[79],"benefit":[80,244,257,351],"is":[81,336],"most":[82,252],"pronounced":[83,260],"higher":[87],"PD-L1":[89,106,127,194,311,345],"expression.":[90,107,195],"We":[91],"report":[92],"results":[93],"<":[103,124,191,308,328],"1%":[104,125,192,309,329],"Methods:":[108],"Pts":[109,164],"(n":[110,212,217],"=":[111,213,218,231,264,271],"550)":[112],"chemo-naive,":[114],"stage":[115],"IV/recurrent":[116],"no":[118],"sensitizing":[120],"EGFR/ALK":[121],"mutations,":[122],"and":[123,134,215,289,307,313,347],"expression":[128,346],"were":[129,165,206,283],"stratified":[130],"by":[131],"histology":[133],"randomized":[135],"1:1:1":[136],"mg/kg":[140,145],"Q2W":[141],"1":[144],"Q6W,":[146],"360":[148],"mg":[149],"Q3W":[150],"chemo,":[152],"(optional":[155],"pemetrexed":[156],"maintenance":[157],"after":[158],"nonsquamous":[161],"[non-SQ]":[162],"NSCLC).":[163],"treated":[166],"up":[167],"2":[169,334],"yr.":[170],"A":[171],"descriptive":[172,241],"analysis":[173],"was":[174,198,222,249,258,314],"performed":[175],"the":[177],"secondary":[178],"PFS":[181,221,243,299],"No":[196],"alpha":[197],"allocated":[199],"this":[201,321,353],"analysis.":[202],"Results:":[203],"Baseline":[204],"characteristics":[205],"balanced":[207],"between":[208],"177)":[214],"186)":[219],"arms.":[220],"improved":[223,298],"(HR":[230,263,270],"0.74":[232],"[95%":[233],"CI:":[234],"0.58,":[235],"0.94];":[236],"minimum":[237],"follow-up":[238],"11.2":[239],"mo;":[240],"comparison).":[242],"observed":[250],"across":[251,355],"subgroups.":[253],"Among":[254],"histologic":[255],"subgroups,":[256],"more":[259],"non-SQ":[262],"0.68)":[265],"relative":[266],"SQ":[268],"NSCLC":[269,306],"0.92).":[272],"Rates":[273],"any":[275],"grade":[276],"tx-related":[277],"adverse":[278],"events":[279],"leading":[280],"discontinuation":[282],"13%":[284],"14%":[290],"chemo.":[292],"Conclusions:":[293],"expression,":[312],"well":[315],"tolerated.":[316],"Results":[317],"are":[318],"encouraging":[319],"analysis,":[322],"which":[323],"includes":[324],"only":[325],"PD-L1.":[330],"Part":[333],"(ongoing)":[335],"evaluating":[337],"irrespective":[343],"will":[348],"further":[349],"inform":[350],"from":[352],"combination":[354],"different":[356],"subgroups":[357],"NSCLC.":[359],"Clinical":[360],"trial":[361],"information:":[362],"NCT02477826.":[363]},"counts_by_year":[{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":39},{"year":2018,"cited_by_count":16}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2018-09-27T00:00:00"}